Related Experiment Video

Updated: Aug 18, 2025

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

16.0K

Evidence-Based Minireview: Should caplacizumab be used routinely in unselected patients with immune thrombotic

George Goshua1,2, Pavan K Bendapudi3,4,5

  • 1Section of Hematology, Yale University School of Medicine, New Haven, CT.

Hematology. American Society of Hematology. Education Program
|December 9, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

13.8K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.0K

Related Experiment Videos

Last Updated: Aug 18, 2025

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

16.0K
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

13.8K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.0K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

16
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
16
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

827
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
827

Articles linked to this work by shared authors, journal, and citation graph.

American Society of Hematology 2026 guidelines for diagnosis of iron deficiency.

Blood advances·2026

Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A.

Blood vessels, thrombosis & hemostasis·2026

Duffy Testing to Benefit Children's Population Health: A Cost-Effectiveness Analysis.

Blood advances·2026

Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysis.

Blood·2026

Cost-effectiveness of iron deficiency screening in pregnancy across ferritin-based thresholds.

Blood advances·2026

Cost-effectiveness of frontline eltrombopag with immunosuppressive therapy for severe aplastic anemia.

Blood red cells & iron·2026

CAR T-cell therapy and bispecific antibodies in the management of multiple myeloma.

Hematology. American Society of Hematology. Education Program·2025

Emerging immunotherapy advances for non-Hodgkin lymphomas: engaging T cells in the fight.

Hematology. American Society of Hematology. Education Program·2025

Anticoagulants in hematologic malignancies: what is the data?

Hematology. American Society of Hematology. Education Program·2025

Diagnosis and management of cold agglutinin disease.

Hematology. American Society of Hematology. Education Program·2025

What to know about rare B-cell malignancies in 2025.

Hematology. American Society of Hematology. Education Program·2025

Peri-transplant conundrums: optimizing maintenance therapy using MRD-directed approaches.

Hematology. American Society of Hematology. Education Program·2025

Heavy menstrual bleeding in women with a bleeding disorder of unknown cause: a common symptom impacting daily life functioning.

Research and practice in thrombosis and haemostasis·2026

ICD-Coded Versus Undiagnosed Acute Kidney Injury in the Atherosclerosis Risk in Communities (ARIC) Study.

Kidney medicine·2026

Ruptured vertebral artery-origin aneurysm causing mediastinal compression and massive hemothorax in neurofibromatosis type 1.

Journal of vascular surgery cases and innovative techniques·2026

Subclavian-to-internal carotid artery bypass with carotid endarterectomy for total occlusion of the common carotid artery under awake neurologic monitoring: a case series.

Frontiers in cardiovascular medicine·2026

Totally Thoracoscopic Atrial Fibrillation Ablation With the Gemini S Bipolar Clamp: A Single-Center Descriptive Cohort Study of 1-Year Rhythm, Safety, and Quality-of-Life Outcomes.

Journal of arrhythmia·2026

Ruptured left gastric artery aneurysm presenting with life-threatening intraperitoneal hemorrhage: a rare vascular emergency.

Jornal vascular brasileiro·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us